BRAF mutations have a very high frequency in hairy cell leukemia (80–100%) [23], melanoma (30–70%) [24], papillary thyroid tumors (36–83%) [16], type I ovarian (30%) [25] and colorectal cancer (10%) [26]. Here, BRAF is linked to melanoma.